Purpose. To review the radiology and histology of synthetic bone grafts resected from patients with recurrent giant cell tumour (GCT) of bone. Methods. 22 patients underwent curettage and grafting for GCT of bone using autogenous cancellous bone mixed with apatite-wollastonite-containing glass ceramic (AWGC), hydroxyapatite (HA), or a mixture of HA and tricalcium phosphate (TCP). Patients were followed up every 3 to 6 months. Three men and 3 women aged 20 to 33 (mean, 27) years developed local recurrence. The mean interval from surgery to recurrence was 35 (range, 12-89) months. Specimens containing the recurring GCT of bone and the surrounding synthetic bone and new bone were evaluated. Results. No complication related to the use of the synthetic bone (such as toxicity, fracture or deformity) occurred. The synthetic bone incorporated well into the surrounding host bone, but was not completely absorbed. HA was more bioactive than AWGC in human bone. HA/TCP were more bioresorbable and Radiological and histological analysis of synthetic bone grafts in recurring giant cell tumour of bone: a retrospective study
INTRODUCTION
Bone grafts can be divided broadly into autografts, allografts, and synthetic grafts. Autografts are osteogenic, osteoinductive, and osteoconductive because they consist of viable cells, matrix proteins, and bony matrix, respectively. 1 Bone defects are usually treated with autografts harvested from the ilium, but the amount available is limited. Synthetic bones including apatite-wollastonite-containing glass ceramic (AWGC), hydroxyapatite (HA), and tricalcium phosphate (TCP) are biocompatible, bioactive, and osteoconductive. [2] [3] [4] [5] They are useful and safe for filling of bone defects after tumour resection. [6] [7] [8] [9] Histological analysis of these materials from human samples has been reported. [8] [9] [10] We reviewed the radiology and histology of grafted bone resected from patients with recurrent tumours.
MATERIALS AND METHODS
Between 1995 and 2005, 22 patients underwent curettage and grafting for giant cell tumours (GCT) of bone. The pseudocapsule was dissected circumferentially and excised completely. The entire intra-osseous lesion was curetted, followed by mechanical burring until the normal bone was exposed. The cavity was packed with mixtures of synthetic and autogenous cancellous bones.
The synthetic bone used from 1995 to 2000 was AWGC (Cerabone; Nippon Electric Glass, Ohtsu, Japan) with porosity of 70%, pore size of 200 µm, and 900 to 1200ºC sintering temperature. The synthetic bone used from 2001 to 2005 was either pure HA (Apaceram; Asahi Optical, Tokyo, Japan) with porosity of 45%, pore size of 5 to 200 µm, and 1200ºC sintering temperature, or a mixture of HA and TCP (Ceratite; Chugai, Tokyo, Japan) in a ratio of 7:3 with porosity of 35%, pore size of 1 to 15 µm, and 1100ºC sintering temperature.
Patients were followed up every 3 to 6 months. Increase in radiographic density of the radiolucent zone surrounding the grafted bone was recorded. Three men and 3 women aged 20 to 33 (mean, 27) years developed local recurrence in the proximal tibia (n=3), distal femur (n=2), and proximal fibula (n=1), which were all confirmed by magnetic resonance imaging. The mean interval from surgery to recurrence was 35 (range, 12-89) months. Three patients had AWGC grafts, 2 had HA grafts, and one had HA/TCP grafts. One patient with recurrence in the proximal fibula underwent en bloc resection without reconstruction. The remaining 5 patients underwent further curettage and grafting with synthetic bone or methylmethacrylate.
Specimens containing the recurring GCT of bone and the surrounding synthetic bone and new bone were evaluated using paraffin sections of 3 µm stained with haematoxylin and eosin.
RESULTS
No complication related to the use of the synthetic bone (such as toxicity, fracture or deformity) occurred. The radiographic density of the grafted bone increased with time. Granules of the synthetic bone had attached to each other at the medullary side and extended cortically. The synthetic bone incorporated well into the surrounding host bone, but was not completely absorbed. Recurring tumours were typically located in the subchondral bone near the cortical window, and partially intruded into the absorbed synthetic bone (Fig. 1) .
Radiologically, most areas of AWGC grafts were hypointense, and granules were distinguishable as void signals on both T1-and T2-weighted images. The surrounding areas were isointense on T1-and hyperintense on T2-weighted images (Fig. 2) . The centres of HA-containing grafts were isointense on T1-and hyperintense on T2-weighted images. The circumference was hypointense on both T1-and T2-weighted images, and the granules were indistinguishable (Fig. 3) . Histologically, most areas of AWGC grafts showed intervening layers of fibrous connective tissue between the granules and the bone. Only a small portion of the graft interface was the newly formed lamellar with osteoblasts attached to the granules (Fig. 4) . In most areas of HA grafts, however, the granules were completely surrounded by viable bone, with bone ingrowth into the pores of the granules, as well as venules, and fibrous tissue ingrowth into the pores of portions of the grafts (Fig. 5) . Recurring tumour cells were in direct contact with the synthetic bone and extended into the pores. Large numbers of multinucleated giant cells surrounded the granules of synthetic bone (Fig. 6) .
DISCUSSION
This retrospective study was not a comparative study of AWGC and HA. In patients with HA-containing grafts, the formation of osteons in the pores was evident, as was the ingrowth of the venules and fibrous tissue into the pores. In a study in which a porous HA block was placed into the proximal tibial metaphysis of dogs, 3 at 12 months 66.5% of the implant surface was covered with bone ingrowth.
AWGC was less bioactive than HA in human bone. Although AWGC was shown to contact newly formed bone directly in experimental animals, 2,4 in our study there were intervening layers of fibrous connective tissue between the granules and the bone, with different signal intensity from the bone trabeculae.
HA/TCP were more bioresorbable and osteoconductive in human bone than HA or AWGC. Resorption of synthetic bone involves a solution-mediated process (the implant dissolves in physiologic solutions) and a cell-mediated process (phagocytosis). 11 Partial dissolution of the synthetic bone in the former process initiates the accumulation of phagocytic cells (macrophages or osteoclasts), which play a major role in resorption. In our study, accumulation of osteoclasts around the graft was not identified, but multinucleated giant cells were noted to surround the granules of the HA/TCP graft only. This suggests that HA/ TCP has a more aggressive cell-mediated process of resorption than HA or AWGC. Additionally, Cathepsin K, a cysteine protease, is expressed in both osteoclasts (responsible for the degradation of collagen matrix during bone remodelling) and multinucleated giant cells (responsible for osteolysis) in GCTs. 12 A variety of synthetic bone grafts have been used to promote new bone formation and structural support. They achieve mechanical strength immediately after grafting by stimulating osteoconduction. Most synthetic bones provide an osteoconductive lattice upon which host osteogenesis can take place. Autogenous cancellous bone should be added to provide osteoinductivity. Therefore, a mixture of synthetic bone and autogenous cancellous bone is preferable.
